Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $10.40, but opened at $10.78. Gyre Therapeutics shares last traded at $10.25, with a volume of 2,428 shares traded.
Gyre Therapeutics Stock Performance
The business’s 50-day moving average price is $12.16 and its 200-day moving average price is $14.46.
Insider Activity at Gyre Therapeutics
In other news, Director Nassim Usman sold 3,452 shares of Gyre Therapeutics stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $12.00, for a total transaction of $41,424.00. Following the transaction, the director now directly owns 1,636 shares of the company’s stock, valued at approximately $19,632. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.92% of the stock is owned by company insiders.
Institutional Trading of Gyre Therapeutics
About Gyre Therapeutics
Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.
Read More
- Five stocks we like better than Gyre Therapeutics
- What is Short Interest? How to Use It
- 3 Stocks That Could Beat the September Blues
- What is a SEC Filing?
- Canopy Growth Stock: Can It Sustain Recent Gains?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Serve Robotics Is Serving Up a Selling Opportunity
Receive News & Ratings for Gyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.